Clinical Trial
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent]
[Article in
Italian]
- PMID: 37462
Item in Clipboard
Clinical Trial
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent]
[Article in
Italian]
Minerva Cardioangiol.
1979 Mar.
No abstract available
Similar articles
-
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.Int J Clin Pharmacol Biopharm. 1979 Oct;17(10):380-5. Int J Clin Pharmacol Biopharm. 1979. PMID: 40887 Clinical Trial. No abstract available.
-
Evaluation and treatment of the hypertensive patient.Prim Care. 1983 Mar;10(1):3-20. Prim Care. 1983. PMID: 6136051 No abstract available.
-
[Evaluation of combination drug therapy in the malignant phase of arterial hypertension].Srp Arh Celok Lek. 1983 Jul;111(7):905-18. Srp Arh Celok Lek. 1983. PMID: 6144190 Serbian. No abstract available.
-
[Calcium antagonists in the treatment of arterial hypertension].Klin Med (Mosk). 1985 Nov;63(11):9-15. Klin Med (Mosk). 1985. PMID: 2868150 Review. Russian. No abstract available.
-
[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].Rev Esp Cardiol. 1999;52 Suppl 3:59-72. Rev Esp Cardiol. 1999. PMID: 10614151 Review. Spanish.